Abeona Therapeutics (ABEO) Dividends payables (2010 - 2014)

Abeona Therapeutics' Dividends payables history runs 5 years deep, the most recent figure standing at $9.3 million for Q3 2014.

• On a quarterly basis, Dividends payables rose 58.04% year-over-year to $9.3 million in Q3 2014; TTM through Sep 2014 was $9.3 million, a 58.04% increase from a year earlier, with the FY2013 full-year figure at $6.7 million, up 91.14% from the prior year.
• Dividends payables rose to $9.3 million in Q3 2014 per ABEO's latest filing, from $8.4 million in the prior quarter.
• Across five years, Dividends payables topped out at $9.3 million in Q3 2014 and bottomed at $2.8 million in Q3 2012.
• The 5-year median for Dividends payables is $6.0 million (2011), against an average of $6.0 million.
• Across the five-year window, Dividends payables slumped 53.65% in 2012 and surged 112.3% in 2013, its largest moves.
• Year by year, Dividends payables stood at $4.4 million in 2010, then jumped by 46.0% to $6.5 million in 2011, then tumbled by 46.26% to $3.5 million in 2012, then jumped by 91.14% to $6.7 million in 2013, then jumped by 39.23% to $9.3 million in 2014.
• Per Business Quant, the three latest ABEO Dividends payables figures stand at $9.3 million (Q3 2014), $8.4 million (Q2 2014), and $7.5 million (Q1 2014).